uncomplicated influenza
Showing 26 - 50 of 3,001
COVID-19, Influenza Trial in United States (Lucira COVID-19 & Flu Test)
Completed
- COVID-19
- Influenza
- Lucira COVID-19 & Flu Test
-
Cullman, Alabama
- +6 more
Nov 16, 2023
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults
Recruiting
- Influenza
- +2 more
- Adjuvanted Quadrivalent Inactivated Influenza Vaccine (aIIV4)
- High-Dose Quadrivalent Inactivated Influenza Vaccine (HD-IIV4)
-
Oakland, CaliforniaKaiser Permanente Northern California (entire region)
Sep 1, 2023
Lower Respiratory Tract Infection Trial in Brooklyn, Haifa, Tel Aviv (MeMed BV test)
Not yet recruiting
- Lower Respiratory Tract Infection
- MeMed BV test
-
Brooklyn, New York
- +2 more
Feb 27, 2023
Influenza, Behavior and Behavior Mechanisms Trial in Hellerup (Behavioral Economic Principles)
Recruiting
- Influenza
- Behavior and Behavior Mechanisms
- Behavioral Economic Principles
-
Hellerup, Hovedstaden, DenmarkCenter for Translational Cardiology and Pragmatic Randomized Tri
Sep 8, 2023
Efficacy, Malaria, Chloroquine Trial in Arba Minch (Chloroquine, Primaquine)
Completed
- Efficacy
- +3 more
-
Arba Minch, South Ethiopia, EthiopiaShecha Health Center
Sep 19, 2023
Quadrivalent Influenza Vaccine Immunization Schedule for
Completed
- GCP
- Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
-
Jinan, Shandong, ChinaKou Zengqiang
Oct 17, 2023
Influenza Vaccine, Cost-Effectiveness, Vaccination Trial in Rajshahi (Quadrivalent Influenza Vaccine)
Recruiting
- Influenza Vaccine
- +2 more
- Quadrivalent Influenza Vaccine
-
Rajshahi, BangladeshRajshahi Medical College Hospital
Aug 13, 2023
Influenza, Behavior and Behavior Mechanisms Trial in Hellerup (Behavioral Economic Principles)
Recruiting
- Influenza
- Behavior and Behavior Mechanisms
- Behavioral Economic Principles
-
Hellerup, Hovedstaden, DenmarkCenter for Translational Cardiology and Pragmatic Randomized Tri
Sep 8, 2023
Influenza A, Pandemic Influenza Trial in Oslo (H7HLAII)
Recruiting
- Influenza A
- Pandemic Influenza
- H7HLAII
-
Oslo, NorwayOslo University Hospital
Sep 20, 2023
Influenza, Influenza Immunization Trial in United States (Influenza Hemagglutinin mRNA vaccine, Quadrivalent Recombinant
Completed
- Influenza
- Influenza Immunization
- Influenza Hemagglutinin mRNA vaccine
- Quadrivalent Recombinant Influenza Vaccine
-
Rolling Hills Estates, California
- +19 more
Oct 31, 2023
Influenza A, Influenza Type B, Coronavirus Disease 2019 Trial in Ballarat (LIAISON NES FLU A/B & COVID-19)
Not yet recruiting
- Influenza A
- +2 more
- LIAISON NES FLU A/B & COVID-19
-
Ballarat, Victoria, AustraliaGrampians Health
Jun 7, 2023
Influenza, COVID-19, Influenza Immunogencity Trial in United States (Simultaneous Vaccination (Influenza Vaccine and mRNA COVID
Not yet recruiting
- Influenza
- +3 more
- Simultaneous Vaccination (Influenza Vaccine and mRNA COVID booster)
- +2 more
-
Phoenix, Arizona
- +7 more
Aug 30, 2023
Clinical Audit, Quality Improvement Trial in Vancouver (Portrait, Therapeutics Letter)
Completed
- Clinical Audit
- Quality Improvement
- Portrait
- Therapeutics Letter
-
Vancouver, British Columbia, CanadaTherapeutics Initiative - Dept of Anesthesiology, Pharmacology &
Apr 4, 2023
Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)
Not yet recruiting
- Influenza, Human
- aQIV
- QIV
-
Batumi, Georgia
- +16 more
Oct 11, 2023
Treatment Compliance Trial in Karachi (to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli
Recruiting
- Treatment Compliance
- to evaluate the safety and efficacy of Ansa for the treatment of UTi and control of Ecoli infection
-
Karachi, Sindg, Pakistan
- +1 more
Oct 6, 2022
Vaccination; Infection, Influenza Trial in Dongguang (Health education)
Recruiting
- Vaccination; Infection
- Influenza
- Health education
-
Dongguang, Guangdong, ChinaDongguang Center for Disease Control and Prevention
Sep 20, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Invasive Candidiasis Trial (therapy duration)
Not yet recruiting
- Invasive Candidiasis
- therapy duration
- (no location specified)
Mar 8, 2023
Influenza Trial in Lima (FLUAD Quadrivalent, FluQuadri)
Active, not recruiting
- Influenza
- FLUAD Quadrivalent
- FluQuadri
-
Lima, Peru
- +1 more
Sep 19, 2023
Urinary Tract Infections, UTI, UTI - Lower Urinary Tract Infection Trial in London (Pacran and Sapnov P quillaja)
Recruiting
- Urinary Tract Infections
- +2 more
- Pacran and Sapnov P quillaja
-
London, Ontario, CanadaSt. Joseph's Health Care London
Jan 13, 2023
Solid Organ Transplant Trial in Minneapolis (Fluzone High-Dose Quadrivalent- 2 doses, Fluzone High-Dose Quadrivalent- 1 dose)
Not yet recruiting
- Solid Organ Transplant
- Fluzone High-Dose Quadrivalent- 2 doses
- Fluzone High-Dose Quadrivalent- 1 dose
-
Minneapolis, MinnesotaUniversity of Minnesota
Dec 20, 2022
Vaccination; Infection Trial (Vaccine injection)
Not yet recruiting
- Vaccination; Infection
- Vaccine injection
- (no location specified)
Oct 12, 2023
SARS-CoV-2, Influenza, RSV Trial in Australia, United Kingdom, United States (mRNA-1010, mRNA-1345, mRNA-1273.214)
Recruiting
- SARS-CoV-2
- +2 more
- mRNA-1010
- +4 more
-
DeLand, Florida
- +29 more
Jan 23, 2023
Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])
Completed
- Influenza
- +4 more
- Influenza vaccine [inactivated]
-
Kol'tsovo, Novosibirsk Region, Russian Federation
- +4 more
May 11, 2023
Complicated Urinary Tract Infection, Acute Pyelonephritis Trial in Meegomäe (co-administration of cefepime and nacubactam,
Recruiting
- Complicated Urinary Tract Infection
- Acute Pyelonephritis
- co-administration of cefepime and nacubactam
- +2 more
-
Meegomäe, Voru, EstoniaMeiji Research Site
May 24, 2023